ZyVersa Therapeutics (ZVSA) Misses Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts ZVSA Hot Sheet
Join SI Premium – FREE
ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q1 EPS of ($0.22).
For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Adjust Monthly US Director's Cut List
- UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
- JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
